duloxetine recall – The FDA says Breckenridge Pharmaceutical recalled nearly 360,000 bottles of duloxetine delayed-release capsules on June 4 after finding high levels of nitrosamines, chemical compounds that may increase cancer risk. The recall covers 30-mg and 60-mg strengths d
On June 4, Breckenridge Pharmaceutical pulled nearly 360,000 bottles of duloxetine—an antidepressant many people rely on every day—after the FDA flagged high levels of nitrosamines, a chemical compound that may increase the risk of cancer.
The recall covers the duloxetine delayed-release capsules, including both 30-mg and 60-mg sizes, and the medications were distributed nationwide.
For the 30-mg capsules, the FDA says the recalled product carries lot code 241180C with an expiration date of April 2027.
For the 60-mg capsules, the FDA’s recall notice lists multiple lot codes and expiration dates affected:
Expiration date November 2026, lot code 232311. Expiration date January 2027, lot code 240316. Expiration date February 2027, lot codes 240317, 240318, 240315C, 240373C, 240370C, 240375C, and 240413C. Expiration date April 2027, lot codes 240978C and 241052C. Expiration date May 2027, lot code 241074C.
If you have any of these recalled duloxetine medications, the guidance is to contact a doctor or pharmacist about next steps.
Experts stress that people should not stop taking the medication without speaking to a medical professional first—an instruction that lands differently for patients who may already be managing symptoms week to week. not just reading a label. The recall may be about one chemical finding. but the immediate question for families is practical and urgent: what happens next. and how quickly can treatment be adjusted safely?.
duloXetine recall duloxetine Cymbalta generic FDA recall nitrosamines antidepressant recall Breckenridge Pharmaceutical delayed-release capsules